We are live on !
Find out more
TS
Third Security Portfolio holdings
AUM
$241M
Turnover
0%
1-Year Est. Return
45.43%
This Fund
S&P 500
This Quarter Est. Return
-9.73%
1 Year Est. Return
-45.43%
3 Year Est. Return
-28.24%
5 Year Est. Return
-58.7%
10 Year Est. Return
–
AUM
$1.71B
AUM Growth
-$143M
(-7.7%)
Cap. Flow
+$73.8M
Cap. Flow % of AUM
Cap. Flow %
4.31%
Top 10 Holdings %
Top 10 Hldgs %
98.75%
Holding
17
New
1
Increased
–
Reduced
1
Closed
1
Avg Time Held
3
years
Top 10 Avg Time Held
2.6
years
Top 20 Avg Time Held
3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AquaBounty Technologies
AQB
|
+$85.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Precigen
PGEN
|
+$9.5M |
| 2 |
Precipio
PRPO
|
+$2.15M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 92.24% |
| 2 | Consumer Staples | 3.94% |
| 3 | Energy | 3.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Precigen
PGEN
$2.37B
| $1.23B | 72.12% |
62,301,326
-427,267
| -0.7% | -$9.5M |
2013 Q3
14 quarters
|
|
2
Halozyme
HALO
$14B
| $250M | 14.61% |
19,305,403
| – | – |
2013 Q2
15 quarters
|
|
|
3
AquaBounty Technologies
AQB
$5.51M
| $67.5M | 3.94% |
+304,640
| New | +$85.5M |
2017 Q1
0 quarters
|
|
4
Alaunos Therapeutics
TCRT
$7.82M
| $61.6M | 3.6% |
64,731
| – | – |
2013 Q2
15 quarters
|
|
5
Enterprise Products Partners
EPD
$79.4B
| $28.6M | 1.67% |
1,035,834
| – | – |
2013 Q2
15 quarters
|
|
6
Energy Transfer Partners
ET
$69.6B
| $14.8M | 0.87% |
752,400
| – | – |
2013 Q2
15 quarters
|
|
|
FCSC
7
DELISTED
Fibrocell Science Inc.
FCSC
| $11.1M | 0.65% |
1,108,028
| – | – |
2013 Q2
15 quarters
|
|
8
Theriva Biologics
TOVX
$9.5M
| $8.35M | 0.49% |
1,513
| – | – |
2013 Q2
15 quarters
|
|
9
Genesis Energy
GEL
$1.7B
| $7.04M | 0.41% |
217,000
| – | – |
2013 Q2
15 quarters
|
|
10
Oragenics
OGEN
$1.94M
| $6.8M | 0.4% |
860
| – | – |
2013 Q2
15 quarters
|
|
11
DELISTED
NuStar Energy L.P.
NS
| $6.06M | 0.35% |
116,500
| – | – |
2013 Q2
15 quarters
|
|
|
TCP
12
DELISTED
TC Pipelines LP
TCP
| $5.79M | 0.34% |
97,000
| – | – |
2013 Q2
15 quarters
|
|
13
Ocugen
OCGN
$274M
| $4.66M | 0.27% |
44,843
| – | – |
2014 Q4
9 quarters
|
|
|
ETP
14
DELISTED
Energy Transfer Partners L.p.
ETP
| $3.11M | 0.18% |
85,135
| – | – |
2015 Q2
7 quarters
|
|
15
Soligenix
SNGX
$7.48M
| $1.18M | 0.07% |
1,822
| – | – |
2016 Q4
1 quarter
|
|
16
Tempest Therapeutics
TPST
$10.4M
| $698K | 0.04% |
128
| – | – |
2013 Q4
13 quarters
|
|
|
17
Precipio
PRPO
$39.5M
| – | – |
-839
| Closed | -$2.15M | – |
|
Similar funds
KRC
A
AIA
FG
RFA
UIA
GCM
GMA
Third Security's Q1 2017 Portfolio in Review
As of Q1 2017, Third Security held 17 positions worth $1.71B, down 7.7% from $1.86B the previous quarter. Its ten largest holdings account for 99% of the portfolio.
Third Security deployed $73.8M of net new capital in Q1 2017, opening 1 new position. Its largest new stake was AquaBounty Technologies: 304,640 shares worth $67.5M.
By sector, the portfolio is most concentrated in Healthcare at 92% of assets, down from 97% a quarter earlier, followed by Consumer Staples and Energy.
On the sell side, the largest reduction was Precigen, an estimated $9.5M trimmed.
- Third Security's largest Q1 2017 buy was AquaBounty Technologies: 304,640 shares worth $67.5M.
- Third Security's biggest Q1 2017 reduction was Precigen, cutting an estimated $9.5M.
- Third Security fully exited Precipio in Q1 2017, selling an estimated $2.15M.
- Third Security's ten largest holdings make up 99% of its $1.71B portfolio in Q1 2017.
- Third Security opened 1 new position and closed 1 in Q1 2017.
- Third Security's portfolio value fell 7.7% quarter-over-quarter to $1.71B.
Based on Third Security's 13F filing for Q1 2017, filed 3 May 2017.